Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Mar. 31, 2021
Current assets    
Cash $ 126,768 $ 30,778
Restricted cash 394 340
Accounts receivable, net 263,139 61,985
Prepaid expenses and other current assets 20,570 4,282
Total current assets 410,871 97,385
Property and equipment, net 31,086 13,050
Right-of-use assets 15,439 3,495
Intangible assets, net 440,589 53,300
Goodwill 559,792 80,176
Deferred tax assets, net 0 12,963
Other non-current assets 732 0
TOTAL ASSETS 1,458,509 260,369
Current liabilities    
Accounts payable 167,858 34,953
Accrued license fees and revenue share 95,170 46,196
Accrued compensation 28,775 9,817
Acquisition purchase price liabilities 50,000 0
Short-term debt 12,500 14,557
Other current liabilities 30,960 5,626
Total current liabilities 385,263 111,149
Long-term debt, net of debt issuance costs 520,785 0
Deferred tax liabilities, net 19,976 0
Other non-current liabilities 16,270 4,108
Total liabilities 942,294 115,257
Commitments and contingencies
Stockholders' equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 745,661 373,310
Treasury stock (758,125 shares at March 31, 2022 and March 31, 2021) (71) (71)
Accumulated other comprehensive loss (39,341) (903)
Accumulated deficit (191,788) (227,334)
Total stockholders' equity 514,571 145,112
Non-controlling interest 1,644 0
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,458,509 $ 260,369